IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
30.27
-1.25 (-3.97%)
At close: Feb 13, 2026, 4:00 PM EST
30.87
+0.60 (1.98%)
After-hours: Feb 13, 2026, 5:46 PM EST

IDEAYA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,6542,2212,293874910407
Market Cap Growth
28.57%-3.15%162.34%-3.92%123.69%168.50%
Enterprise Value
1,5441,0401,784484530125
Last Close Price
30.2725.7035.5818.1723.6414.00
PS Ratio
12.43317.3398.0717.1732.5720.82
PB Ratio
2.432.103.692.503.022.05
P/TBV Ratio
2.432.103.692.503.022.05
P/FCF Ratio
-----7.40
P/OCF Ratio
-----7.33
EV/Sales Ratio
7.19148.5676.319.5118.966.40
EV/FCF Ratio
-----2.27
Debt / Equity Ratio
0.030.020.010.010.020.03
Debt / FCF Ratio
-----0.12
Net Debt / Equity Ratio
-1.02-1.00-1.01-1.06-1.20-1.40
Net Debt / EBITDA Ratio
5.383.284.776.127.488.15
Net Debt / FCF Ratio
10.534.235.364.086.21-5.04
Asset Turnover
0.180.010.050.130.080.10
Quick Ratio
12.2014.6819.3811.515.497.39
Current Ratio
12.4414.9719.6511.685.567.47
Return on Equity (ROE)
-14.15%-32.67%-23.28%-18.02%-19.91%-23.10%
Return on Assets (ROA)
-10.77%-23.05%-16.20%-10.15%-9.25%-10.74%
Return on Capital Employed (ROCE)
-18.60%-30.30%-21.60%-17.50%-15.00%-13.60%
Earnings Yield
-6.06%-12.36%-4.92%-6.71%-5.47%-8.48%
FCF Yield
-3.97%-11.32%-5.13%-10.37%-6.42%13.51%
Buyback Yield / Dilution
-15.78%-42.00%-38.79%-17.57%-42.60%-97.82%
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q